Dispelling the Malaria-Typhoid Co-infection Myth in Nigeria: A Literature Review
Keywords:
Malaria, Typhoid, Malaria-Typhoid co-infection, Widal test, Multi-microbial resistanceAbstract
Malaria and typhoid fever are public health concerns in Nigeria, with high prevalence rates. The perception of a widespread co-infection between these diseases may be misleading, due to limitations in diagnostic methods, particularly the Widal test for typhoid fever. This literature review examines the prevalence of malaria-typhoid co-infection in Nigeria and identifies factors contributing to misdiagnosis, including non-specific symptoms, limited diagnostic resources, and the diagnostic accuracy of tests employed. Additionally, the review discusses the implications of misdiagnosis, such as the overuse of broad-spectrum antibiotics leading to a rising incidence of antimicrobial resistance. Strategies to address this issue are explored, emphasizing the need for improved diagnostic methods, enhanced healthcare provider education, and comprehensive health education campaigns to empower patients and curb antibiotic misuse. While acknowledging limitations in available research done in Nigeria, this review underscores the urgency of addressing the malaria-typhoid co-infection myth to improve healthcare outcomes and combat antimicrobial resistance in Nigeria.
References
S.-O. Ia, “Prevalence of Malaria and Typhoid Coinfection in Relation to Haematological Profile of University Students in Akure, Nigeria”, doi: 10.23937/2474-3658/1510166.
“Report on malaria in Nigeria 2022,” WHO | Regional Office for Africa. Accessed: Mar. 29, 2024. [Online]. Available: https://www.afro.who.int/countries/nigeria/publication/report-malaria-nigeria-2022
K. O. Akinyemi et al., “Typhoid Fever: Tracking the Trend in Nigeria,” Am. J. Trop. Med. Hyg., vol. 99, no. 3 Suppl, pp. 41–47, Sep. 2018, doi: 10.4269/ajtmh.18-0045.
J. Nakisuyi et al., “Prevalence and factors associated with malaria, typhoid, and co-infection among febrile children aged six months to twelve years at kampala international university teaching hospital in western Uganda,” Heliyon, vol. 9, no. 9, p. e19588, Aug. 2023, doi: 10.1016/j.heliyon.2023.e19588.
admin, “Incidence of malaria/typhoid co-infection among adult population in Unwana community, Afikpo North local government area, Ebonyi state, southeastern Nigeria,” Take on Typhoid. Accessed: Apr. 01, 2024. [Online]. Available: https://www.coalitionagainsttyphoid.org/publications/incidence-of-malaria-typhoid-co-infection-among-adult-population-in-unwana-community-afikpo-north-local-government-area-ebonyi-state-southeastern-nigeria/
N. Awunor and O. Enabulele, “Typhoid fever in a tertiary hospital in Nigeria: another look at the Widal agglutination test as a preferred option for diagnosis,” J. Niger. Med. Assoc., vol. 57, pp. 145–149, Oct. 2016.
T. Rufai et al., “Malaria and typhoid fever among patients presenting with febrile illnesses in Ga West Municipality, Ghana,” PLOS ONE, vol. 18, no. 5, p. e0267528, May 2023, doi: 10.1371/journal.pone.0267528.
A. Mawazo, G. M. Bwire, and M. I. N. Matee, “Performance of Widal test and stool culture in the diagnosis of typhoid fever among suspected patients in Dar es Salaam, Tanzania,” BMC Res. Notes, vol. 12, p. 316, Jun. 2019, doi: 10.1186/s13104-019-4340-y.
“Widal Test - Introduction, Principle and Procedure | Metropolis,” Metropolis India Lab. Accessed: Apr. 01, 2024. [Online]. Available: https://www.metropolisindia.com/blog/health-wellness/widal-test-introduction-principle-procedure-preparation-price
“CDC - Parasites - Malaria.” Accessed: Mar. 29, 2024. [Online]. Available: https://www.cdc.gov/parasites/malaria/index.html
“Fact sheet about malaria.” Accessed: Mar. 29, 2024. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/malaria
N. O. Adeboye, O. V. Abimbola, and S. O. Folorunso, “Malaria patients in Nigeria: Data exploration approach,” Data Brief, vol. 28, p. 104997, Dec. 2019, doi: 10.1016/j.dib.2019.104997.
“Typhoid.” Accessed: Mar. 29, 2024. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/typhoid
S. Batire et al., “Magnitude of Malaria-Typhoid Fever Coinfection in Febrile Patients at Arba Minch General Hospital in Southern Ethiopia,” J. Trop. Med., vol. 2022, p. 2165980, Aug. 2022, doi: 10.1155/2022/2165980.
K. O. Akinyemi, B. S. Bamiro, and A. O. Coker, “Salmonellosis in Lagos, Nigeria: Incidence of Plasmodium falciparum-associated Co-infection, Patterns of Antimicrobial Resistance, and Emergence of Reduced Susceptibility to Fluoroquinolones,” J. Health Popul. Nutr., vol. 25, no. 3, pp. 351–358, Sep. 2007.
L. I. Uzairue et al., “Antimicrobial resistance and virulence genes of invasive Salmonella enterica from children with bacteremia in north-central Nigeria,” SAGE Open Med., vol. 11, p. 20503121231175322, 2023, doi: 10.1177/20503121231175322.
J. Bhandari, P. K. Thada, and E. DeVos, “Typhoid Fever,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2024. Accessed: Apr. 01, 2024. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK557513/
“Presumptive treatment of malaria from formal and informal drug vendors in Nigeria - PubMed.” Accessed: Mar. 30, 2024. [Online]. Available: https://pubmed-ncbi-nlm-nih-gov.dartmouth.idm.oclc.org/25333909/
“WHO and partners take on malaria: the top killer in north-eastern Nigeria.” Accessed: Apr. 01, 2024. [Online]. Available: https://www.who.int/news-room/feature-stories/detail/who-and-partners-take-on-malaria-the-top-killer-in-north-eastern-nigeria
B. T. Ugwu, S. J. Yiltok, A. T. Kidmas, and A. S. Opaluwa, “Typhoid intestinal perforation in north central Nigeria,” West Afr. J. Med., vol. 24, no. 1, pp. 1–6, 2005, doi: 10.4314/wajm.v24i1.28152.
M. E. Ohanu, M. O. Iroezindu, U. Maduakor, O. D. Onodugo, and H. C. Gugnani, “Typhoid fever among febrile Nigerian patients: Prevalence, diagnostic performance of the Widal test and antibiotic multi-drug resistance,” Malawi Med. J., vol. 31, no. 3, pp. 184–192, Sep. 2019, doi: 10.4314/mmj.v31i3.4.
E. Zieli?ski, M. Kowalczyk, K. Osowiecka, ?. Klepacki, ?. Dy?ko, and K. Wojtysiak, “The Problem of Antimalarial-Drug Abuse by the Inhabitants of Ghana,” Medicina (Mex.), vol. 59, no. 2, p. 257, Jan. 2023, doi: 10.3390/medicina59020257.
E. E. Chukwu et al., “A national survey of public awareness of antimicrobial resistance in Nigeria,” Antimicrob. Resist. Infect. Control, vol. 9, p. 72, May 2020, doi: 10.1186/s13756-020-00739-0.
O. G. Ajakaye and M. R. Ibukunoluwa, “Performance evaluation of a popular malaria RDT in Nigeria compared with microscopy,” J. Parasit. Dis. Off. Organ Indian Soc. Parasitol., vol. 44, no. 1, pp. 122–125, Mar. 2020, doi: 10.1007/s12639-019-01170-y.
M. A. Oboh, E. C. Oriero, T. Ndiaye, A. S. Badiane, D. Ndiaye, and A. Amambua-Ngwa, “Comparative analysis of four malaria diagnostic tools and implications for malaria treatment in southwestern Nigeria,” Int. J. Infect. Dis., vol. 108, pp. 377–381, Jul. 2021, doi: 10.1016/j.ijid.2021.05.049.
W. M. Stauffer et al., “Superior Diagnostic Performance of Malaria Rapid Diagnostic Tests as compared to Blood Smears in U.S. Clinical Practice,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 49, no. 6, pp. 908–913, Sep. 2009, doi: 10.1086/605436.
A. Adhikari, R. Rauniyar, P. P. Raut, K. D. Manandhar, and B. P. Gupta, “Evaluation of sensitivity and specificity of ELISA against Widal test for typhoid diagnosis in endemic population of Kathmandu,” BMC Infect. Dis., vol. 15, p. 523, Nov. 2015, doi: 10.1186/s12879-015-1248-6.
J. Sapkota et al., “Comparative Analysis of Commercially Available Typhoid Point-of-Care Tests: Results of a Prospective and Hybrid Retrospective Multicenter Diagnostic Accuracy Study in Kenya and Pakistan,” J. Clin. Microbiol., vol. 60, no. 12, pp. e01000-22, Nov. 2022, doi: 10.1128/jcm.01000-22.
F. A. Mbuh, M. Galadima, and L. Ogbadu, “Rate of co-infection with malaria parasites and Salmonella typhi in Zaria, Kaduna State, Nigeria,” Ann. Afr. Med., vol. 2, no. 2, Art. no. 2, 2003.
“CDC in Nigeria | Global Health | CDC.” Accessed: Mar. 30, 2024. [Online]. Available: https://www.cdc.gov/globalhealth/countries/nigeria/default.htm
“NaTHNaC - Nigeria: Rising cases of Lassa fever.” Accessed: Mar. 30, 2024. [Online]. Available: https://travelhealthpro.org.uk/news/691/nigeria-rising-cases-of-lassa-fever
“Antimicrobial resistance (AMR).” Accessed: Mar. 30, 2024. [Online]. Available: https://www.healthdata.org/research-analysis/health-risks-issues/antimicrobial-resistance-amr
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Sciences: Basic and Applied Research (IJSBAR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who submit papers with this journal agree to the following terms.
